期刊文献+

HER2胞外区基因的克隆及其在大肠杆菌中的可溶性表达 被引量:1

Soluble Expression of Extracellular Region of HER2 in Escherichia coli
下载PDF
导出
摘要 采用反转录PCR和PCR方法分别克隆P185HER2n/eu胞外区基因和噬菌体M13KO7g3p-N1结构域基因,然后将二者偶联入pET-22b(+)载体中,在大肠杆菌中进行融合表达。可溶性目的蛋白表达量占细菌可溶性表达产物总量的30%左右,并通过镍亲和层析纯化出目的蛋白。以上结果为从噬菌体抗体库中筛选抗P185HER2/neu的抗体奠定了基础。 The extracellular region gene of human P185HER2/neu and the gene of g3p-N1 domain were amplified by RT-PCR and PCR from sk-br-3 cell and M13KO7 phage respectively. Fused to 3'-terminus of the gene of g3p-N1 domain, the extracellular region gene of human P185HER2/neu was high-efficiently expressed in host E.coli by vector pET-22b(+). The fusion protein attaining to the 30% of the total protein which could be soluble expressed in E.coli was conveniently purified by chelating column (HisTrap HP Columns). This research made the basis of screening anti-P185HER2/neu antibody from recombinant phage-display antibody library.
出处 《生物技术通讯》 CAS 2005年第3期252-254,共3页 Letters in Biotechnology
  • 相关文献

参考文献7

  • 1Semba K,Kamata N.A v-erbB-related protooncogene,c-erbB-2,is distinct from the c-erbB-1/epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma[J].Proc Natl Acad Sci USA,1985,82:6497.
  • 2Bargmann CI,Hung MC,Weinberg RA,et al.The neu oncogene encodes an epidermal growth factor receptor-related protein[J].Nature, 1986,1319(6050):226.
  • 3Agus DB,Bum PAJR,Franklin W,et al.HER2/neu as a therapeutic target in non-small cell lung cancer,postate cancer,and overian cancer[J]. Semiu Oncol,2000,27(6 suppl 11):53263.
  • 4Stebbing J,Copson E,O'Reilly S.Herceptin (trastuzamab) in advanced breast cancer[J].Cancer Treat Rev,2000,26(4):287.
  • 5Cho HS,Mason K,Ramyar K,et al.Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab [J].Nature, 2003,421:756.
  • 6Christian F,Bodo B,Ralf O,et al.From EST to IHC:human antibody pipeline for target research[J].Immunol Methods,2003,75:203.
  • 7张效云,孙志伟,王双,俞炜源.人CD20胞外区与噬菌体pⅢ融合基因在E.coli中的可溶性表达[J].军事医学科学院院刊,2004,28(4):347-349. 被引量:1

同被引文献16

  • 1沈倍奋.治疗性抗体的改造[J].医学分子生物学杂志,2006,3(4):245-249. 被引量:9
  • 2Jemal A, Siegel P, Ward E, et al. Cancer statistics. CA Cancer J Clin, 2007, 57:43 - 66
  • 3Gotdenberg M M. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther, 1999, 21 (2) : 309 -318
  • 4Viani G A, Afonso S L, Stefano E J, et al. Adjuvant trastuzumah in the treatment of her-2- positive early breast cancer: a meta-analysis of published randomized trials . BMC Caneer, 2007, 7 : 153
  • 5Yeon C H, Pegram M D. Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer. Investigational New Drugs,2005,23:391-409
  • 6Swinkels B W, van Ooyen A J, Bonekamp F J. The yeast Kluyveromyces lactis as an efficient host for heterologous gene expression. Antonie van Leeuwenhoek, 1993, 64 (2) : 187 - 201
  • 7Dujon B, Sherman D, Fisher G, et al. Genome evolution in yeasts . Nature, 2004,430:35 - 44
  • 8Albert J J, van Ooyen, Prter Dekker, et al. Heterologous protein production in the yeast Kluyveromyces lactis. FEMS Yeast Res,2006 (6) :381 - 392
  • 9Swenncn D, Paul M F, Vernis L, et al. Secretion of active anti -Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis. Microbiology ,2002,148 : 41 - 50
  • 10Robin S, Petrov K, Dintinger T, et al. Comparison of three microbial hosts for the expression of an active catalytic scFv. Mol Immunol,2003,39(12) :729 -738

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部